SPTB

SPTB encodes erythrocyte β-spectrin, a cytoskeletal protein whose CH1/CH2 domains mediate binding to erythrocyte membrane actin and whose spectrin repeat domains support assembly of the membrane skeleton through interaction with ankyrin; pathogenic loss-of-function variants destabilize this skeleton and convert discoid erythrocytes into spherocytes, causing hereditary spherocytosis (PMID:35099593). The dominant mechanism across the corpus is haploinsufficiency arising from premature termination: frameshift, nonsense, and splice-disrupting variants generate transcripts bearing premature stop codons that are degraded by nonsense-mediated mRNA decay, lowering SPTB mRNA and β-spectrin protein levels (PMID:35099593, PMID:39521890, PMID:40551579). Many disease alleles act at the level of splicing—splice-donor abolition, cryptic-site activation, intronic inversion, and exon skipping all yield frameshifted, prematurely terminated transcripts and reduced expression (PMID:39135028, PMID:33943044, PMID:31922588, PMID:38111681, PMID:40090920, PMID:41321563). De novo SPTB mutations frequently manifest as monoallelic expression, accounting for apparently recessive spherocytosis in children of hematologically normal parents (PMID:9609518). Structurally, deletion of the CH1/CH2-encoding exons produces a β-spectrin unable to engage membrane actin (PMID:36765497). Beyond this erythrocyte membrane-skeleton role and its perturbation by reduced expression, no additional molecular functions are characterized in the available corpus.

1. 1990 Medium

   Before its chromosomal assignment, the genomic location of erythrocyte β-spectrin was undefined; mapping the gene anchored SPTB as a discrete locus for linkage to inherited red-cell disorders.

   Evidence In situ hybridization and somatic cell hybrid analysis with a cDNA probe

   PMID:2209094

   Open questions at the time

   • Does not address protein function or disease mechanism
   • No mutation-phenotype link established
2. 1998 Medium

   It was unclear why isolated spectrin-deficient spherocytosis could appear recessive in families with normal parents; allele-specific expression analysis showed de novo SPTB mutations frequently cause monoallelic expression, reframing inheritance as dominant haploinsufficiency masked by failure of mutant allele accumulation.

   Evidence RT-PCR on patient cDNA with polymorphism-based allele tracking in multiple patients

   PMID:9609518

   Open questions at the time

   • Mechanism of mRNA non-accumulation not resolved at the molecular level
   • Does not directly demonstrate NMD
3. 2022 Medium

   How a single frameshift allele produces disease was unresolved; functional analysis tied a frameshift variant to disrupted β-spectrin synthesis and localization, weakened β-spectrin–ankyrin interaction, and NMD, linking genotype to spherocyte formation.

   Evidence Patient blood analysis, interaction/co-immunoprecipitation assay, and NMD pathway assessment

   PMID:35099593

   Open questions at the time

   • Methods described at abstract level only
   • Single lab; β-spectrin–ankyrin interaction not quantified by orthogonal assay
4. 2020 High

   Whether intronic splice-site variants are pathogenic required functional proof; orthogonal in vitro and patient-RNA splicing assays showed a c.5798+1G>A variant causes frameshift and premature termination, establishing splicing disruption as a disease mechanism.

   Evidence pCAS2 minigene splicing assay in 293T cells plus in vivo RT-PCR from patient blood with TA cloning

   PMID:31922588

   Open questions at the time

   • Protein-level loss not directly measured in this study
   • Single lab
5. 2021 Medium

   The structural consequence of splice variants on the protein was unclear; demonstration that c.1064+1G>A causes exon 8 exclusion, frameshift, and a premature stop predicted to truncate all spectrin repeat domains connected aberrant splicing to loss of the functional skeleton-assembly region.

   Evidence RT-PCR and TA cloning sequencing in patient samples with family co-segregation

   PMID:33943044

   Open questions at the time

   • Truncation of spectrin repeats inferred, not protein-verified
   • Single lab
6. 2023 Low

   It was unknown whether structural rearrangements and CH-domain loss contribute to SPTB disease; an intronic inversion was shown to cause exon 20 skipping with reduced mRNA, and CNV deletion of CH1/CH2-encoding exons was inferred to abolish actin binding, expanding the variant spectrum.

   Evidence RNA sequencing of patient material (inversion); RT-qPCR plus UniProt/SMART domain analysis (CNV deletion)

   PMID:36765497 PMID:38111681

   Open questions at the time

   • Actin-binding loss is computational/database inference, not directly tested
   • Single cases per variant
7. 2024 Medium

   Whether premature-termination alleles act via mRNA decay needed direct measurement; quantitative mRNA analysis in CD34+-derived erythroblasts and a minigene assay confirmed NMD-mediated reduction and aberrant splicing, solidifying haploinsufficiency as the unifying mechanism.

   Evidence In vitro erythroblast culture with real-time PCR (frameshift/nonsense); minigene splicing reporter assay (splice variant)

   PMID:39135028 PMID:39521890

   Open questions at the time

   • Protein-level consequences not assayed in these systems
   • Single lab per study
8. 2025 High

   Linking transcript defects to actual protein loss closed a key gap; Western blot showed frameshift/nonsense variants decrease β-spectrin protein, and combined RT-PCR/cDNA/qRT-PCR/Western analysis confirmed a splice-donor mutation causes exon loss with reduced mRNA and protein, while cryptic-site activation drives NMD.

   Evidence Western blot of patient material; multi-method splicing and expression analysis (RT-PCR, cDNA sequencing, qRT-PCR, Western blot, mRNA sequencing) across affected family members

   PMID:40090920 PMID:40551579 PMID:41321563

   Open questions at the time

   • Membrane-skeleton structural consequences not directly imaged
   • Single lab per variant

• How quantitatively reduced β-spectrin translates into graded membrane-skeleton instability and clinical severity, and whether any non-erythroid or interaction-specific functions of SPTB exist, remains uncharacterized in this corpus.
• No structural model of mutant skeleton assembly
• β-spectrin–ankyrin interaction tested in only one study
• No quantitative genotype-severity relationship established